Deals
GE Healthcare CEO Sheds Dealmaking Image to Seek Growth Within
- Unit of U.S. conglomerate seeks to raise profit margin in 2016
- Sales growth likely to come from software, life sciences: CEO
This article is for subscribers only.
John Flannery built a reputation as a prolific rainmaker in his previous role as head of business development at General Electric Co., logging more than $26 billion in deals, yet acquisitions are far from his mind as chief executive of the U.S. conglomerate’s health-care unit.
Instead, Flannery is looking within for growth, even after revenue from diagnostic-imaging machines slowed. The company offers a wide range of products and services, including ventilators, software and tools to support drug manufacturing.